Durgical
EN
Open the app

HTLV-1 paraparesis of the Colombian Pacific

  • Syndrome

A virus passed through breast milk, sex or blood can, decades later, slowly stiffen the legs and upset the bladder. Tumaco made it famous.

Updated

See it in 3D: Spinal cord · Mid-back nerve roots

What it is

HTLV-1-associated myelopathy, also called tropical spastic paraparesis, is a chronic inflammatory myelopathy in a small share of people infected with human T-lymphotropic virus type 1. It produces a slowly progressive, symmetric spastic weakness of the legs, an overactive bladder, low back pain and mild sensory symptoms, usually starting in adulthood. HTLV-1 is endemic in parts of the Colombian Pacific coast, where Colombian researchers described Pacific spastic paraparesis and were among the first to link it to the virus. Diagnosis rests on the clinical picture, HTLV-1 antibodies in blood and CSF and exclusion of other causes; treatment is mostly symptomatic.

How to recognise it

  • Onset is insidious, usually in middle age, more often in women; it progresses over years, not days.
  • Early symptoms: stiff or heavy legs, urinary urgency, frequency or incontinence, constipation and low back pain.
  • Examination: brisk leg reflexes, extensor plantars, clonus and a scissoring spastic gait; often brisk arm reflexes too.
  • Sensory findings are mild: tingling or burning feet, sometimes reduced vibration; a sharp sensory level is unusual.
  • Other HTLV-1 illnesses can coexist: uveitis, infective dermatitis in children, strongyloides hyperinfection and adult T-cell leukaemia/lymphoma.
  • MRI may be normal or show a thin (atrophic) thoracic cord; brain white matter spots can appear.

Why it happens

  • HTLV-1 is a retrovirus that integrates into CD4 T cells and spreads by cell-to-cell contact, so it passes with cells in milk, semen and blood.
  • A high proviral load and a strong cytotoxic response drive chronic inflammation around cord vessels.
  • The lower thoracic lateral columns are hit most, giving bilateral upper motor neuron weakness of the legs and loss of bladder control.

Slow spastic legs: HTLV-1 and its look-alikes

CauseTempoDistinguishing clueConfirming test
HTLV-1 myelopathyYearsEndemic origin, bladder early, mild sensory changeHTLV-1 antibodies in blood and CSF
Cervical spondylotic myelopathyMonths to yearsNeck pain, hand clumsiness, arm signsCervical MRI with compression
Primary progressive MSYearsBrain and cord lesions on MRIMRI, CSF oligoclonal bands
B12 or copper deficiencyWeeks to monthsMarked vibration and position lossB12, methylmalonic acid, copper
Hereditary spastic paraplegiaYears, family historyLittle bladder or sensory involvementGenetic testing

Differential diagnosis

  • Cervical spondylosis is common in older adults and may coexist: an HTLV-1 test is still needed in endemic origin.
  • Primary progressive multiple sclerosis looks similar, but brain lesions and oligoclonal bands are typical and HTLV-1 is negative.
  • Hereditary spastic paraplegia has a family history and usually spares the bladder until late.
  • A positive HTLV-1 test in a carrier does not prove the cause: compression, B12 and syphilis are excluded too.

Next step

  • HTLV-1/2 antibody screen, confirmed by a second method (immunoblot or PCR); test the CSF as well.
  • MRI of the whole spine and brain to exclude compression and other myelopathies.
  • Exclude mimics: B12, copper, syphilis serology, HIV test.
  • Blood count and smear for abnormal lymphocytes (flower cells) if adult T-cell leukaemia is possible.
  • Symptomatic plan: antispasticity drugs, bladder assessment, physiotherapy and walking aids; advise against breastfeeding and blood donation, and offer testing to partners and children.

Common traps

  • A positive HTLV-1 serology means the patient will develop paraparesis: most carriers remain healthy for life, so counselling stresses low lifetime risk.
  • Spastic legs with a normal MRI exclude a cord disease: HTLV-1 myelopathy often shows a normal or only thin cord.
  • Bladder symptoms are a separate urological problem: an overactive bladder is often the first sign of the myelopathy.
  • HTLV-1 is the same as HIV: both are retroviruses, but HTLV-1 causes myelopathy and T-cell leukaemia rather than immunodeficiency.

Test yourself

Think of the answer, then tap the question to see it.

A woman from Tumaco has four years of stiff legs and urinary urgency. Reflexes are brisk, sensation nearly normal, MRI shows no compression. What is the key test and why?

HTLV-1 serology confirmed by a second method, in blood and CSF: slow spastic paraparesis with early bladder symptoms in someone from the Colombian Pacific is classic HTLV-1 myelopathy.

Why does advice for an HTLV-1-positive mother focus on breastfeeding?

The virus spreads in infected lymphocytes, and prolonged breastfeeding is a main route from mother to child; avoiding it lowers transmission.

Why is HTLV-1 myelopathy mainly a leg and bladder disease rather than a sensory one?

The chronic inflammation targets the lateral columns of the thoracic cord, which carry corticospinal and bladder control fibres, while the dorsal columns are less affected.

An HTLV-1 carrier develops skin lesions, high calcium and abnormal lymphocytes. What should be suspected?

Adult T-cell leukaemia/lymphoma, the other main disease caused by HTLV-1: refer to haematology for smear, flow cytometry and staging.

Add to my cards (4)

Elsewhere in DurgiPedia

Connections

← All of neurology

Educational content; it does not replace supervised training, your institution's protocols or a medical assessment. It contains no doses. For signs of stroke (face drooping, arm weakness, speech trouble), a prolonged seizure or fever with a stiff neck, call the emergency number (123 in Colombia) or go to the nearest emergency department.

Sources: Human T-lymphotropic virus-1 (World Health Organization (WHO), 2024); Association between lymphocytotropic virus type I (HTLV-I) infection and Pacific spastic paraparesis (Colombia Médica (Universidad del Valle), 1986); Transverse Myelitis (National Institute of Neurological Disorders and Stroke (NIH), 2024).

Spotted a mistake?We are always improving for the community. Tell us what is wrong and our team will review it.Report a mistake

Representative model, for educational purposes only.